Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways.
about
Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-EatingSubstrate specificity and sequence-dependent activity of the Saccharomyces cerevisiae 3-methyladenine DNA glycosylase (Mag)An increase in reactive oxygen species by deregulation of ARNT enhances chemotherapeutic drug-induced cancer cell deathDownregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complexMetabolic interrogation as a tool to optimize chemotherapeutic regimens.Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesotheliomaCisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.Cellular responses to Cisplatin-induced DNA damage.Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo.Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancerPropyl-2-(8-(3,4-difluorobenzyl)-2',5'-dioxo-8-azaspiro[bicyclo[3.2.1] octane-3,4'-imidazolidine]-1'-yl) acetate induces apoptosis in human leukemia cells through mitochondrial pathway following cell cycle arrest.Tumor-targeted drug delivery with aptamersThe terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrestHijacking of the mismatch repair system to cause CAG expansion and cell death in neurodegenerative disease.MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.Effect of Sterols Isolated from Myrtillocactus geometrizans on Growth Inhibition of Colon and Breast Cancer Cells.The effect of 3β, 6β, 16β-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells.Candidate mechanisms for chemotherapy-induced cognitive changes.Knock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin.Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes.N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemiaIn Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic ModelLong-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancer.p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cellsRescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling networkBase excision repair of oxidative DNA damage and association with cancer and agingAltered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets.The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin.New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer.Copper, gold and silver compounds as potential new anti-tumor metallodrugs.Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer.Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells.A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin.Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.
P2860
Q27334935-3DA4FC6E-7681-45AB-8342-26979A2B4026Q27937334-AB4800D3-7D98-4D8C-B8AC-3BCD9D6DE990Q28539641-7BB26977-C643-460A-AB0F-8884B3ED57DAQ28821489-F2A453C9-6340-4201-AD6D-F12D9C356F1DQ33566853-0C779B3E-8C88-4C1B-9239-98DF2186076DQ33781389-B267416F-E88B-4DFA-8E3C-9E83C9038A0BQ33822719-D53BBEAB-4646-4445-95CE-D17C1B46E380Q33999822-03A458AA-627F-4EF4-8E5B-6A4D0F760815Q34009832-268E4573-F6F6-4864-97C2-DB0A2CE8AEACQ34089685-D12FC6DF-7C35-4C57-8FC1-D1BF3AB0EDF9Q34458507-0C28CB67-792C-4A2F-9523-067D97735F1AQ34704011-C5DBFDED-9E44-4745-853E-21276596D8C1Q34902156-C956966A-2470-4FAF-9BDB-CACBCFC4465DQ35490874-BA4CC322-14F7-457F-9D0E-73F627CDB0FFQ35497956-2A8C1BFD-CB54-40D7-A32B-B33F3C4FAA63Q35547560-F34F8A09-F411-4841-B329-7A9674DCF5ECQ35632142-FFCA9254-2964-4954-9065-3344FBE46AC4Q35727617-E46EE9E4-2060-491D-9A41-610955C3054AQ35737783-406E75D8-4409-47C7-9539-EE55A9B074D6Q35853383-C0F660B9-E5FA-4E40-B7C6-C18564EF0099Q35898051-2B753465-18F4-4608-BD77-52B5DF94BF23Q36003210-4DBE233F-29AA-41FB-BEC3-57EAB11690C3Q36029514-B3333C43-E892-4FA4-A51B-29FCD0EE81CDQ36055168-D41E8311-FAE2-4A84-A864-8A20570EFBC1Q36118111-5A228D9B-6690-41B5-97EF-70CB2B3C0E53Q36140933-C7EB42A5-506E-4068-A6B1-84B3FFB6B482Q36172748-336F441C-2B8E-4CD6-B9F6-E783DE9A58FAQ36304176-18D3770F-FE14-4DBB-9675-AF67B7AB84C6Q36650466-54A958C8-01CB-4358-808C-7CCC54705818Q36994777-632DC57D-1C05-4EAA-BEFA-0CE84085ACC1Q37090426-CD10A1C3-518B-4D9B-B072-1BA18347785DQ37339508-BD672FF8-7690-42ED-A95D-592E22D4C1E7Q37693895-22D75214-4565-4D21-A6C6-B05DD351223EQ37809986-08925303-8D74-49A9-B201-275C7618693CQ37855898-15625D74-2FC8-4621-9EFE-56F072236546Q38174090-0CCCFC0B-E9AD-4F06-B9F4-17B70C9574A7Q38744268-3098973F-E7A3-4573-B532-76578214F1DCQ39151957-6A90B8F3-F4B5-4E0A-B40D-BD7CF1A9555AQ39181502-8CDDDB73-1770-418A-9261-2901F5B07106Q39323969-108804D4-701B-457B-93EA-891DA1BF231F
P2860
Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@ast
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@en
type
label
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@ast
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@en
prefLabel
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@ast
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@en
P356
P1476
Cisplatin is a DNA-damaging an ...... ortance of apoptotic pathways.
@en
P2093
Jean-Marc Malinge
Yuliya Sedletska
P304
P356
10.2174/1568011053765967
P577
2005-05-01T00:00:00Z